For the Inventor, By the Inventor

Enter assignee name

Lawrence, KS, United States of America

Interx Research Corporation

USPTO Granted Patents = 76

Forward Citations = 1,077

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Nicolae S Bodor (45 out of 47 patents)

Kenneth B Sloan (24 out of 34 patents)

Takeru Higuchi (14 out of 50 patents)

4. James J Kaminski (14 out of 14 patents)

5. Nicholas S Bodor (12 out of 86 patents)

6. Anwar A Hussain (7 out of 37 patents)

7. Sun-Shine Yuan (6 out of 6 patents)

8. Yu-Neng Kuo (4 out of 4 patents)

9. Stefano A Pogany (3 out of 15 patents)

10. Toshiaki Nishihata (3 out of 5 patents)

11. Valentino J Stella (2 out of 50 patents)

12. John J Windheuser (2 out of 3 patents)

13. Jacob A Zupan (1 out of 5 patents)

14. Roy M Little (1 out of 3 patents)

15. Efraim Shek (1 out of 1 patent)

Core Competencies:

Prodrugs

Bioavailability

Antibacterial Agents

Quaternary Ammonium Salts

Glycosidic Agents

Dopamine Derivatives

Anti-inflammatory

Therapeutic Delivery

Xanthine Derivatives

Optically Active Compounds

Sympathomimetic Amines

Non-steroidal Anti-inflammatory

76 patents: Sort by Forward Citations

1. 4727151 - Labile quaternary ammonium salts as prodrugs (1988-02-23),

2. 4470980 - Method of increasing oral absorption of .beta.-lactam antibiotics (1984-09-11),

3. 4462991 - Method of increasing oral absorption of polar bioactive agents (1984-07-31),

4. 4459295 - Method of increasing oral absorption of glycosidic and related (1984-07-10),

5. 4412994 - Mannich-base hydroxamic acid prodrugs, compositions and use (1983-11-01),

6. 4340603 - Novel inotropic prodrugs (1982-07-20),

7. 4313956 - Novel sypathomimetic amine prodrugs (1982-02-02),

8. 4311706 - Novel dopa/dopamine prodrugs (1982-01-19),

9. 4285947 - Aldehyde adducts of triamterene (1981-08-25),

10. 4275219 - Novel process and intermediates useful in the preparation of (1981-06-23),

11. 4275064 - Transient pro-drug forms of xanthine derivatives and their use as (1981-06-23),

12. 4268441 - Prodrugs for improved bioavailability of certain .DELTA..sup.4 (1981-05-19),

13. 4263305 - Novel pyridiniumaldoximes having micellar characteristics (1981-04-21),

14. 4260769 - 5,5-Diphenylhydantoins (1981-04-07),

15. 4252790 - Method for treating gastric ulcer-prone patients (1981-02-24),

Company Overview

Interx Research Corporation, based in Lawrence, Kansas, specializes in the development of prodrugs aimed at enhancing bioavailability and therapeutic delivery. The company focuses on innovative solutions in the pharmaceutical sector, particularly in the areas of antibacterial agents, anti-inflammatory treatments, and various chemical compounds such as quaternary ammonium salts and dopamine derivatives. Their research is dedicated to advancing drug formulations that improve patient outcomes and address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

76 Patents

#3 in Lawrence, KS

#33 in Kansas

#4,846 in US

#9,898 in the World

Lawrence, KS, United States of America

Interx Research Corporation

Forward Citations = 1,077

25 inventors:

Nicolae S Bodor (45 out of 47 patents)

Kenneth B Sloan (24 out of 34 patents)

Takeru Higuchi (14 out of 50 patents)

4. James J Kaminski (14 out of 14 patents)

5. Nicholas S Bodor (12 out of 86 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Interx Research Corporation. Retrieved from https://idiyas.com/company/interx-research

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…